David Brennan, chief executive of AstraZeneca and chairman of The Pharmaceutical Research and Manufactureers of America, will be speaking today at the Medical Innovation Summit in Cleveland. According to the Times Online, he is expected to call for a better-funded, more powerful American drugs regulator to speed up the approval of new treatments and to increase confidence in the industry.
No comments:
Post a Comment